Akagera Medicines Inc.
Waltham, MA
- UEI
- Y6U5VK97MD53
- CAGE
- 0Q1Z4
- Primary NAICS
- 541713 Research and Development in Nanotechnology
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 271 Waverley Oaks Rd #100, Waltham, MA 02452, USA
- Website
- akageramedicines.com
- Founded
- 2018
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Seattle Children's Hospital | 75N93019C00070 | $107,341 |
Quick answers
Is Akagera Medicines Inc. registered in SAM.gov?
Yes. Akagera Medicines Inc.'s SAM.gov registration is active through September 23, 2027.
What is Akagera Medicines Inc.'s CAGE code?
Akagera Medicines Inc.'s CAGE code is 0Q1Z4, and its Unique Entity ID (UEI) is Y6U5VK97MD53.
On GovTribe
See Akagera Medicines Inc.'s full federal record
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors